Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Statement [Abstract]
Revenue	$ 0	$ 240,000
Cost of revenue	(8,083)	125,395
Gross profit	8,083	114,605
Operating expenses:
Research and development	924,367	644,076
General and administrative	1,414,615	1,934,482
Sales and marketing	374,753	267,757
Total operating expenses	2,713,735	2,846,315
Loss from operations	(2,705,652)	(2,731,710)
Other income (expense)
Interest expense	(499,797)	(295,111)
Change in fair value of derivative and warrant liabilities	(154,898)	2,060,749
Amortization of derivative and warrant liabilities discount	(1,127,143)	(1,304,867)
Amortization of deferred debt issuance costs and original issue discount	(281,118)	(694,939)
Gain on extinguishment of debt	302,510	225,830
Other expense, net	(22,183)	(9,597)
Nonoperating Income (Expense)	(1,782,629)	(17,935)
Net loss	$ (4,488,281)	$ (2,749,645)
Basic and diluted loss per share	$ (0.03)	$ (0.02)
Weighted average common shares outstanding	170,237,633	160,015,532